HAL fluorescence cystoscopy and TURB. One year of Romanian experience
2009

Improved Bladder Cancer Detection with Blue Light Cystoscopy

Sample size: 70 publication Evidence: high

Author Information

Author(s): Geavlete B, Mulţescu R, Georgescu D, Jecu M, Geavlete P

Primary Institution: ‘Sf. Ioan’ Clinical Emergency Hospital, Department of Urology, Bucharest, Romania

Hypothesis

HAL fluorescence cystoscopy is a more effective diagnostic tool for non-invasive bladder tumors compared to standard white light cystoscopy.

Conclusion

HAL fluorescence cystoscopy significantly improves diagnostic accuracy and reduces short-term recurrence rates in patients with non-invasive bladder tumors.

Supporting Evidence

  • WLC identified 115 tumors with a detection rate of 68.8%, while BLC identified 157 tumors with a detection rate of 94%.
  • The recurrence rate for the study group was 6.4%, significantly lower than the 24.2% for the control group.
  • BLC showed a diagnostic accuracy of 94% compared to 68.8% for WLC.
  • 51.4% of cases diagnosed with BLC had at least one additional tumor not detected by WLC.

Takeaway

Using a special blue light helps doctors find more bladder tumors than regular light, which means patients can get better treatment.

Methodology

The study involved 70 patients diagnosed with non-invasive bladder tumors, comparing the effectiveness of white light cystoscopy and blue light cystoscopy over a follow-up period of 5 months.

Limitations

The study was limited to a one-year experience and may not account for long-term outcomes.

Participant Demographics

49 men and 21 women, mean age 66 years (range 34 to 83).

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication